Jinan Liangfu Jinghe Pharmaceutical Technology Co., Ltd.
MAILBOX | CHINESE | ENGLISH
Products
API & Intermediates
Cell Signaling Pathway Inhibitors
·Inhibitors of BTK Pathway
·Inhibitors of EGFR pathways
·Inhibitors of VEGFR pathways
·Inhibitors of PDGFR pathways
·Inhibitors of PI3K-Akt-mTOR pathways
·Inhibitors of IGF pathways
·Inhibitors of JAK-STAT pathway
·Inhibitors of MAPK/ERK pathway
·Inhibitors of apoptosis pathway
·Inhibitors of HIF-1 pathway
·Inhibitors of other pathways
Small Molecule Compounds
Impurity Reference Standards
Others
Contact Us
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621
Fax: +86-531-88817925
Zip Code: 250101
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com
Cell Signaling Pathway Inhibitors Now Position:Home > Products > Cell Signaling Pathway Inhibitors < Inhibitors of EGFR pathways
Dacomitinib; PF299804,PF-00299804(CAS:1110813-31-4, 1042385-75-0 (H2O))

Product No.

TP1015A 

Name

Dacomitinib

Synonyms

PF299804,PF-00299804

CAS Number

1110813-31-4, 1042385-75-0 (H2O)

Structure

 

Brief Description

PF299804 is a potent, irreversible pan-ErbB inhibitor against ErbB1, ErbB2 and ErbB4 with IC50 of 6 nM, 45.7 nM and 73.7 nM, respectively.

Purity

>99%

Package

5mg, 10mg, 20mg, 50mg

 





Close
QQ1: 1762738062
QQ2: 1919147143
MSN: sales-trio
SKYPE: janisa.yan